These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16122787)

  • 21. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells.
    Fitzgerald JS; Tsareva SA; Poehlmann TG; Berod L; Meissner A; Corvinus FM; Wiederanders B; Pfitzner E; Markert UR; Friedrich K
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2284-96. PubMed ID: 16125646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells.
    Yang M; Foster E; Kahn AM
    Am J Hypertens; 2005 Oct; 18(10):1329-34. PubMed ID: 16202857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
    Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells.
    Yang M; Kahn AM
    Am J Hypertens; 2006 Jun; 19(6):587-92. PubMed ID: 16733230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NAD(P)H oxidase in paraventricular nucleus contributes to the effect of angiotensin II on cardiac sympathetic afferent reflex.
    Zhang Y; Yu Y; Zhang F; Zhong MK; Shi Z; Gao XY; Wang W; Zhu GQ
    Brain Res; 2006 Apr; 1082(1):132-41. PubMed ID: 16519880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities and differences between effects of angiotensin III and angiotensin II on human prostate cancer cell migration and proliferation.
    Domińska K; Piastowska-Ciesielska AW; Lachowicz-Ochędalska A; Ochędalski T
    Peptides; 2012 Oct; 37(2):200-6. PubMed ID: 22884921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of TNF-α and Ang II on the proliferation, migration and invasion of HepG2 cells by regulating the expression of GRK2.
    Xu ZW; Yan SX; Wu HX; Chen JY; Zhang Y; Li Y; Wei W
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):747-758. PubMed ID: 28315953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells.
    Saward L; Zahradka P
    Circ Res; 1997 Aug; 81(2):249-57. PubMed ID: 9242186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II and III upregulate body fluid volume of the clam worm Perinereis sp. via angiotensin II receptors in different manners.
    Satou R; Nakagawa T; Ido H; Tomomatsu M; Suzuki F; Nakamura Y
    Peptides; 2005 Dec; 26(12):2452-7. PubMed ID: 15993982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation.
    Xia Y; Wen HY; Kellems RE
    J Biol Chem; 2002 Jul; 277(27):24601-8. PubMed ID: 11983698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neferine hinders choriocarcinoma cell proliferation, migration and invasion through repression of long noncoding RNA-CHRF.
    Wang G; Wang P; Yan X; Liu J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4089-4096. PubMed ID: 31630562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells.
    Cambados N; Walther T; Nahmod K; Tocci JM; Rubinstein N; Böhme I; Simian M; Sampayo R; Del Valle Suberbordes M; Kordon EC; Schere-Levy C
    Oncotarget; 2017 Oct; 8(51):88475-88487. PubMed ID: 29179450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway.
    Zhang S; Wang Y
    Oncol Lett; 2018 Apr; 15(4):5859-5864. PubMed ID: 29552215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro studies on the invasion of blood vessel wall by choriocarcinoma cells.
    Chew EC; Cheung SL
    Anticancer Res; 1989; 9(1):133-9. PubMed ID: 2705742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells.
    Al-Nasiry S; Geusens N; Hanssens M; Luyten C; Pijnenborg R
    Hum Reprod; 2007 May; 22(5):1304-9. PubMed ID: 17307808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of acute effects of angiotensin II on atrial electrophysiology in humans.
    Kistler PM; Davidson NC; Sanders P; Fynn SP; Stevenson IH; Spence SJ; Vohra JK; Sparks PB; Kalman JM
    J Am Coll Cardiol; 2005 Jan; 45(1):154-6. PubMed ID: 15629389
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case of extragenital choriocarcinoma in a male].
    PASQUALI E
    Acta Chir Ital; 1954; 10(2):105-26. PubMed ID: 14375581
    [No Abstract]   [Full Text] [Related]  

  • 39. Choriocarcinoma.
    HUNTER JS; DOCKERTY MB
    Obstet Gynecol; 1955 Apr; 5(4):598-612. PubMed ID: 14370706
    [No Abstract]   [Full Text] [Related]  

  • 40. Choriocarcinoma.
    WILSON R; HUNTER J; SYMMONDS R; DOCKERTY M; ALBERT A; BULBULIAN A
    Postgrad Med; 1963 Feb; 33():182-4. PubMed ID: 14001073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.